Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.
Tallman
M S
MS
Robert H. Lurie Cancer Center of Northwestern University, Northwestern University Medical School, Chicago, IL 60611, USA.
Hakimian
D
D
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017338:Cladribine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D015649:Pentostatin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D011684:Purine Nucleosides / Q000627:therapeutic use*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011684:Purine Nucleosides; D015649:Pentostatin; D017338:Cladribine; D014740:Vidarabine; C024352:fludarabine